No associations were found for women with hormone - receptor - positive tumors and for women who received endocrine therapy. (sciencedaily.com)
Thirty - four patients received chemotherapy, and six patients received endocrine therapy. (sciencedaily.com)
Phase III Randomized, Placebo - Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy + / - One Year of Everolimus in Patients with High - Risk, Hormone Receptor - Positive and HER2 / neu Negative Breast Cancer. (vicc.org)